High cost out-of-pocket drugs and obstacles to reduce those prices for patients plague the health industry. With patients in mind, organizations are looking to invest and bring drugs directly to market.
Gaurav Gupta and Hugo Beekman, Co-Founders of Ascendant BioCapital, join the show to discuss their organization and how they’re focusing on drugs that truly make a difference for patients.
What we talked about:
The Founding of Ascendant BioCapital
The Medical & Investing Backgrounds of the Founders
Impactful Experiences in the Industry
Testifying Before Congress & Issues with Out-Of-Pocket Costs
Importance of Intellectual Property to Biotech
To hear more interviews like this one, subscribe to the Making Medicine Podcast on Apple Podcasts, Spotify, or your preferred podcast platform.
